Assessment of the Subcutaneous Reinjection of Human Autologous Adipose-derived Stromal Vascular Fraction (Celution® System) in the Hands of Patients Suffering From Systemic Sclerosis
Phase of Trial: Phase II
Latest Information Update: 05 Dec 2016
At a glance
- Drugs ECCS 50 (Primary)
- Indications Systemic scleroderma
- Focus Therapeutic Use
- Acronyms SCLERADEC I
- 05 Dec 2016 According to a Cytori Therapeutics media release, full data set of this trial will be presented by the Investigators at a forthcoming scientific meeting.
- 05 Dec 2016 Topline review of early three-year follow-up data published in the Cytori Therapeutics Media Release
- 29 Nov 2016 According to a Cytori Therapeutics media release, the two years follow-up results from this study were published in the journal of Current Research in Translational Medicine.